Hohmann, Nicolas; Xia, Ning; Steinkamp-Fenske, Katja et al.
Estrogen Receptor Signaling and the PI3K/Akt Pathway Are Involved in Betulinic Acid-Induced eNOS ActivationMOLECULES. Bd. 21. H. 8. 2016
Steubl, Dominik; Michel, Martin C.
Experimental and clinical nephroprotection by the xanthine oxidase inhibitor febuxostatNAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY. Bd. 389. H. 8. 2016 S. 815-817
Michel, Martin C.
How (3)-adrenoceptor-selective is mirabegron?BRITISH JOURNAL OF PHARMACOLOGY. Bd. 173. H. 3. 2016 S. 429-430
Michel, Martin C.
Impact of Formulation on the Pharmacokinetic Profile of DutasterideCLINICAL DRUG INVESTIGATION. Bd. 36. H. 9. 2016 S. 769-770
Oelze, M.; Steven, S.; Kroeller-Schoen, S. et al.
Improvement of diabetes-induced vascular dysfunction, oxidative stress and inflammation in type 2 diabetic ZDF rats by the sodium-glucose co-transporter 2 inhibitor empagliflozinEUROPEAN HEART JOURNAL. Bd. 37. 2016 S. 1104-1105
Werner, Anke; Amann, Eva; Schnitzius, Vanessa et al.
Induced arginine transport via cationic amino acid transporter-1 is necessary for human T-cell proliferationEUROPEAN JOURNAL OF IMMUNOLOGY. Bd. 46. H. 1. 2016 S. 92-103
Koster, Ursula; Nolte, Ingo; Michel, Martin C.
Longitudinal trends and subgroup analysis in publication patterns for preclinical data of newly approved drugsNAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY. Bd. 389. H. 2. 2016 S. 201-209
Yildirim, Oktay; Gottwald, Matthias; Schueler, Peter et al.
Opportunities and Challenges for Drug Development: Public-Private Partnerships, Adaptive Designs and Big DataFRONTIERS IN PHARMACOLOGY. Bd. 7. 2016
Waisman, Ari; Hoevelmeyer, Nadine; Diefenbach, Andreas et al.
Past, present and future of immunology in MainzCELLULAR IMMUNOLOGY. Bd. 308. 2016 S. 1-6
Koster, Ursula; Nolte, Ingo; Michel, Martin C.
Preclinical research strategies for newly approved drugs as reflected in early publication patternsNAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY. Bd. 389. H. 2. 2016 S. 187-199